カテゴリ： Market Monitor Global, 世界, 医療/バイオ

医療用インサイチュハイブリダイゼーション装置のグローバル市場展望 2023年-2029年：検体数12検体、検体数20検体、検体数40検体

■ 英語タイトル：Medical In Situ Hybridization Instrument Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC13575）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC13575
■ 発行日：2023年12月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医療用インサイチュハイブリダイゼーション装置のグローバル市場展望 2023年-2029年：検体数12検体、検体数20検体、検体数40検体]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の医療用インサイチュハイブリダイゼーション装置市場規模と予測を収録しています。・世界の医療用インサイチュハイブリダイゼーション装置市場：売上、2018年-2023年、2024年-2029年
・世界の医療用インサイチュハイブリダイゼーション装置市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用インサイチュハイブリダイゼーション装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「検体数12検体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医療用インサイチュハイブリダイゼーション装置のグローバル主要企業は、Hölle & Hüttner AG (Intavis)、 Xmatrx、 Abbott、 Danaher Corporation (Leica Biosystems)、 Allsheng、 Hangzhou Allsheng Instruments、 Shenzhen Dartmon Biotechnology、 Zhejiang Orient Gene Biotech、 Gene Tech、 Shanghai Naai Experimental Instrumentなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医療用インサイチュハイブリダイゼーション装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医療用インサイチュハイブリダイゼーション装置市場：タイプ別、2018年-2023年、2024年-2029年
世界の医療用インサイチュハイブリダイゼーション装置市場：タイプ別市場シェア、2022年
・検体数12検体、検体数20検体、検体数40検体

世界の医療用インサイチュハイブリダイゼーション装置市場：用途別、2018年-2023年、2024年-2029年
世界の医療用インサイチュハイブリダイゼーション装置市場：用途別市場シェア、2022年
・遺伝子発現解析、ランダムin situハイブリダイゼーション、免疫細胞化学、その他

世界の医療用インサイチュハイブリダイゼーション装置市場：地域・国別、2018年-2023年、2024年-2029年
世界の医療用インサイチュハイブリダイゼーション装置市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医療用インサイチュハイブリダイゼーション装置のグローバル売上、2018年-2023年
・主要企業における医療用インサイチュハイブリダイゼーション装置のグローバル売上シェア、2022年
・主要企業における医療用インサイチュハイブリダイゼーション装置のグローバル販売量、2018年-2023年
・主要企業における医療用インサイチュハイブリダイゼーション装置のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Hölle & Hüttner AG (Intavis)、 Xmatrx、 Abbott、 Danaher Corporation (Leica Biosystems)、 Allsheng、 Hangzhou Allsheng Instruments、 Shenzhen Dartmon Biotechnology、 Zhejiang Orient Gene Biotech、 Gene Tech、 Shanghai Naai Experimental Instrument

*************************************************************

・調査・分析レポートの概要
医療用インサイチュハイブリダイゼーション装置市場の定義
市場セグメント
世界の医療用インサイチュハイブリダイゼーション装置市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用インサイチュハイブリダイゼーション装置市場規模
世界の医療用インサイチュハイブリダイゼーション装置市場規模：2022年 VS 2029年
世界の医療用インサイチュハイブリダイゼーション装置市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用インサイチュハイブリダイゼーション装置の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用インサイチュハイブリダイゼーション装置製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：検体数12検体、検体数20検体、検体数40検体
医療用インサイチュハイブリダイゼーション装置のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：遺伝子発現解析、ランダムin situハイブリダイゼーション、免疫細胞化学、その他
医療用インサイチュハイブリダイゼーション装置の用途別グローバル売上・予測

・地域別市場分析
地域別医療用インサイチュハイブリダイゼーション装置市場規模 2022年と2029年
地域別医療用インサイチュハイブリダイゼーション装置売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Hölle & Hüttner AG (Intavis)、 Xmatrx、 Abbott、 Danaher Corporation (Leica Biosystems)、 Allsheng、 Hangzhou Allsheng Instruments、 Shenzhen Dartmon Biotechnology、 Zhejiang Orient Gene Biotech、 Gene Tech、 Shanghai Naai Experimental Instrument
...

This research report provides a comprehensive analysis of the Medical In Situ Hybridization Instrument market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Medical In Situ Hybridization Instrument market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Medical In Situ Hybridization Instrument, challenges faced by the industry, and potential opportunities for market players.
The global Medical In Situ Hybridization Instrument market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Medical In Situ Hybridization Instrument market presents opportunities for various stakeholders, including Gene Expression Analysis, Random In Situ Hybridization. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Medical In Situ Hybridization Instrument market. Additionally, the growing consumer demand present avenues for market expansion.
The global Medical In Situ Hybridization Instrument market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Based on the in situ hybridization technology, the medical in situ hybridization instrument can visualize the existence and distribution of the target gene by matching the nucleic acid sequence labeled with a specific DNA or RNA probe with the target gene sequence in the sample to be tested. The medical in situ hybridization instrument usually consists of sample processing system, heating or cooling system, probe and detection system, microscope and imaging system, etc. When using a medical in situ hybridization instrument for experiments or clinical applications, operators should follow the operation manual of the equipment and relevant safety regulations to ensure that the experimental parameters are set correctly and take necessary protective measures to ensure the safety of personnel and the accuracy of results .
Key Features:
The research report on the Medical In Situ Hybridization Instrument market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Medical In Situ Hybridization Instrument market.
Market Overview: The report provides a comprehensive overview of the Medical In Situ Hybridization Instrument market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Sample Capacity 12 Pieces, Sample Capacity 20 Pieces), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Medical In Situ Hybridization Instrument market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Medical In Situ Hybridization Instrument market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Medical In Situ Hybridization Instrument market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Medical In Situ Hybridization Instrument market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Medical In Situ Hybridization Instrument market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Medical In Situ Hybridization Instrument market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Medical In Situ Hybridization Instrument, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Medical In Situ Hybridization Instrument market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Medical In Situ Hybridization Instrument market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Sample Capacity 12 Pieces
Sample Capacity 20 Pieces
Sample Capacity 40 Pieces
Market segment by Application
Gene Expression Analysis
Random In Situ Hybridization
Immunocyto Chemistry
Others
Global Medical In Situ Hybridization Instrument Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Hölle & Hüttner AG (Intavis)
Xmatrx
Abbott
Danaher Corporation (Leica Biosystems)
Allsheng
Hangzhou Allsheng Instruments
Shenzhen Dartmon Biotechnology
Zhejiang Orient Gene Biotech
Gene Tech
Shanghai Naai Experimental Instrument
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical In Situ Hybridization Instrument, market overview.
Chapter 2: Global Medical In Situ Hybridization Instrument market size in revenue and volume.
Chapter 3: Detailed analysis of Medical In Situ Hybridization Instrument manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical In Situ Hybridization Instrument in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical In Situ Hybridization Instrument capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Medical In Situ Hybridization Instrument Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical In Situ Hybridization Instrument Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical In Situ Hybridization Instrument Overall Market Size
2.1 Global Medical In Situ Hybridization Instrument Market Size: 2022 VS 2029
2.2 Global Medical In Situ Hybridization Instrument Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical In Situ Hybridization Instrument Sales: 2018-2029
3 Company Landscape
3.1 Top Medical In Situ Hybridization Instrument Players in Global Market
3.2 Top Global Medical In Situ Hybridization Instrument Companies Ranked by Revenue
3.3 Global Medical In Situ Hybridization Instrument Revenue by Companies
3.4 Global Medical In Situ Hybridization Instrument Sales by Companies
3.5 Global Medical In Situ Hybridization Instrument Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical In Situ Hybridization Instrument Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical In Situ Hybridization Instrument Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical In Situ Hybridization Instrument Players in Global Market
3.8.1 List of Global Tier 1 Medical In Situ Hybridization Instrument Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical In Situ Hybridization Instrument Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical In Situ Hybridization Instrument Market Size Markets, 2022 & 2029
4.1.2 Sample Capacity 12 Pieces
4.1.3 Sample Capacity 20 Pieces
4.1.4 Sample Capacity 40 Pieces
4.2 By Type – Global Medical In Situ Hybridization Instrument Revenue & Forecasts
4.2.1 By Type – Global Medical In Situ Hybridization Instrument Revenue, 2018-2023
4.2.2 By Type – Global Medical In Situ Hybridization Instrument Revenue, 2024-2029
4.2.3 By Type – Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
4.3 By Type – Global Medical In Situ Hybridization Instrument Sales & Forecasts
4.3.1 By Type – Global Medical In Situ Hybridization Instrument Sales, 2018-2023
4.3.2 By Type – Global Medical In Situ Hybridization Instrument Sales, 2024-2029
4.3.3 By Type – Global Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
4.4 By Type – Global Medical In Situ Hybridization Instrument Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical In Situ Hybridization Instrument Market Size, 2022 & 2029
5.1.2 Gene Expression Analysis
5.1.3 Random In Situ Hybridization
5.1.4 Immunocyto Chemistry
5.1.5 Others
5.2 By Application – Global Medical In Situ Hybridization Instrument Revenue & Forecasts
5.2.1 By Application – Global Medical In Situ Hybridization Instrument Revenue, 2018-2023
5.2.2 By Application – Global Medical In Situ Hybridization Instrument Revenue, 2024-2029
5.2.3 By Application – Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
5.3 By Application – Global Medical In Situ Hybridization Instrument Sales & Forecasts
5.3.1 By Application – Global Medical In Situ Hybridization Instrument Sales, 2018-2023
5.3.2 By Application – Global Medical In Situ Hybridization Instrument Sales, 2024-2029
5.3.3 By Application – Global Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
5.4 By Application – Global Medical In Situ Hybridization Instrument Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical In Situ Hybridization Instrument Market Size, 2022 & 2029
6.2 By Region – Global Medical In Situ Hybridization Instrument Revenue & Forecasts
6.2.1 By Region – Global Medical In Situ Hybridization Instrument Revenue, 2018-2023
6.2.2 By Region – Global Medical In Situ Hybridization Instrument Revenue, 2024-2029
6.2.3 By Region – Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
6.3 By Region – Global Medical In Situ Hybridization Instrument Sales & Forecasts
6.3.1 By Region – Global Medical In Situ Hybridization Instrument Sales, 2018-2023
6.3.2 By Region – Global Medical In Situ Hybridization Instrument Sales, 2024-2029
6.3.3 By Region – Global Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical In Situ Hybridization Instrument Revenue, 2018-2029
6.4.2 By Country – North America Medical In Situ Hybridization Instrument Sales, 2018-2029
6.4.3 US Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.4.4 Canada Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.4.5 Mexico Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical In Situ Hybridization Instrument Revenue, 2018-2029
6.5.2 By Country – Europe Medical In Situ Hybridization Instrument Sales, 2018-2029
6.5.3 Germany Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5.4 France Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5.5 U.K. Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5.6 Italy Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5.7 Russia Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5.8 Nordic Countries Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.5.9 Benelux Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical In Situ Hybridization Instrument Revenue, 2018-2029
6.6.2 By Region – Asia Medical In Situ Hybridization Instrument Sales, 2018-2029
6.6.3 China Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.6.4 Japan Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.6.5 South Korea Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.6.6 Southeast Asia Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.6.7 India Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical In Situ Hybridization Instrument Revenue, 2018-2029
6.7.2 By Country – South America Medical In Situ Hybridization Instrument Sales, 2018-2029
6.7.3 Brazil Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.7.4 Argentina Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical In Situ Hybridization Instrument Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical In Situ Hybridization Instrument Sales, 2018-2029
6.8.3 Turkey Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.8.4 Israel Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.8.5 Saudi Arabia Medical In Situ Hybridization Instrument Market Size, 2018-2029
6.8.6 UAE Medical In Situ Hybridization Instrument Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Hölle & Hüttner AG (Intavis)
7.1.1 Hölle & Hüttner AG (Intavis) Company Summary
7.1.2 Hölle & Hüttner AG (Intavis) Business Overview
7.1.3 Hölle & Hüttner AG (Intavis) Medical In Situ Hybridization Instrument Major Product Offerings
7.1.4 Hölle & Hüttner AG (Intavis) Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.1.5 Hölle & Hüttner AG (Intavis) Key News & Latest Developments
7.2 Xmatrx
7.2.1 Xmatrx Company Summary
7.2.2 Xmatrx Business Overview
7.2.3 Xmatrx Medical In Situ Hybridization Instrument Major Product Offerings
7.2.4 Xmatrx Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.2.5 Xmatrx Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Medical In Situ Hybridization Instrument Major Product Offerings
7.3.4 Abbott Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 Danaher Corporation (Leica Biosystems)
7.4.1 Danaher Corporation (Leica Biosystems) Company Summary
7.4.2 Danaher Corporation (Leica Biosystems) Business Overview
7.4.3 Danaher Corporation (Leica Biosystems) Medical In Situ Hybridization Instrument Major Product Offerings
7.4.4 Danaher Corporation (Leica Biosystems) Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.4.5 Danaher Corporation (Leica Biosystems) Key News & Latest Developments
7.5 Allsheng
7.5.1 Allsheng Company Summary
7.5.2 Allsheng Business Overview
7.5.3 Allsheng Medical In Situ Hybridization Instrument Major Product Offerings
7.5.4 Allsheng Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.5.5 Allsheng Key News & Latest Developments
7.6 Hangzhou Allsheng Instruments
7.6.1 Hangzhou Allsheng Instruments Company Summary
7.6.2 Hangzhou Allsheng Instruments Business Overview
7.6.3 Hangzhou Allsheng Instruments Medical In Situ Hybridization Instrument Major Product Offerings
7.6.4 Hangzhou Allsheng Instruments Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.6.5 Hangzhou Allsheng Instruments Key News & Latest Developments
7.7 Shenzhen Dartmon Biotechnology
7.7.1 Shenzhen Dartmon Biotechnology Company Summary
7.7.2 Shenzhen Dartmon Biotechnology Business Overview
7.7.3 Shenzhen Dartmon Biotechnology Medical In Situ Hybridization Instrument Major Product Offerings
7.7.4 Shenzhen Dartmon Biotechnology Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.7.5 Shenzhen Dartmon Biotechnology Key News & Latest Developments
7.8 Zhejiang Orient Gene Biotech
7.8.1 Zhejiang Orient Gene Biotech Company Summary
7.8.2 Zhejiang Orient Gene Biotech Business Overview
7.8.3 Zhejiang Orient Gene Biotech Medical In Situ Hybridization Instrument Major Product Offerings
7.8.4 Zhejiang Orient Gene Biotech Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.8.5 Zhejiang Orient Gene Biotech Key News & Latest Developments
7.9 Gene Tech
7.9.1 Gene Tech Company Summary
7.9.2 Gene Tech Business Overview
7.9.3 Gene Tech Medical In Situ Hybridization Instrument Major Product Offerings
7.9.4 Gene Tech Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.9.5 Gene Tech Key News & Latest Developments
7.10 Shanghai Naai Experimental Instrument
7.10.1 Shanghai Naai Experimental Instrument Company Summary
7.10.2 Shanghai Naai Experimental Instrument Business Overview
7.10.3 Shanghai Naai Experimental Instrument Medical In Situ Hybridization Instrument Major Product Offerings
7.10.4 Shanghai Naai Experimental Instrument Medical In Situ Hybridization Instrument Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai Naai Experimental Instrument Key News & Latest Developments
8 Global Medical In Situ Hybridization Instrument Production Capacity, Analysis
8.1 Global Medical In Situ Hybridization Instrument Production Capacity, 2018-2029
8.2 Medical In Situ Hybridization Instrument Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical In Situ Hybridization Instrument Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical In Situ Hybridization Instrument Supply Chain Analysis
10.1 Medical In Situ Hybridization Instrument Industry Value Chain
10.2 Medical In Situ Hybridization Instrument Upstream Market
10.3 Medical In Situ Hybridization Instrument Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical In Situ Hybridization Instrument Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Medical In Situ Hybridization Instrument in Global Market
Table 2. Top Medical In Situ Hybridization Instrument Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Medical In Situ Hybridization Instrument Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Medical In Situ Hybridization Instrument Revenue Share by Companies, 2018-2023
Table 5. Global Medical In Situ Hybridization Instrument Sales by Companies, (Units), 2018-2023
Table 6. Global Medical In Situ Hybridization Instrument Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Medical In Situ Hybridization Instrument Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Medical In Situ Hybridization Instrument Product Type
Table 9. List of Global Tier 1 Medical In Situ Hybridization Instrument Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medical In Situ Hybridization Instrument Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Medical In Situ Hybridization Instrument Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Medical In Situ Hybridization Instrument Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Medical In Situ Hybridization Instrument Sales (Units), 2018-2023
Table 15. By Type - Global Medical In Situ Hybridization Instrument Sales (Units), 2024-2029
Table 16. By Application – Global Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Medical In Situ Hybridization Instrument Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Medical In Situ Hybridization Instrument Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Medical In Situ Hybridization Instrument Sales (Units), 2018-2023
Table 20. By Application - Global Medical In Situ Hybridization Instrument Sales (Units), 2024-2029
Table 21. By Region – Global Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Medical In Situ Hybridization Instrument Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Medical In Situ Hybridization Instrument Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Medical In Situ Hybridization Instrument Sales (Units), 2018-2023
Table 25. By Region - Global Medical In Situ Hybridization Instrument Sales (Units), 2024-2029
Table 26. By Country - North America Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Medical In Situ Hybridization Instrument Sales, (Units), 2018-2023
Table 29. By Country - North America Medical In Situ Hybridization Instrument Sales, (Units), 2024-2029
Table 30. By Country - Europe Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Medical In Situ Hybridization Instrument Sales, (Units), 2018-2023
Table 33. By Country - Europe Medical In Situ Hybridization Instrument Sales, (Units), 2024-2029
Table 34. By Region - Asia Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Medical In Situ Hybridization Instrument Sales, (Units), 2018-2023
Table 37. By Region - Asia Medical In Situ Hybridization Instrument Sales, (Units), 2024-2029
Table 38. By Country - South America Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Medical In Situ Hybridization Instrument Sales, (Units), 2018-2023
Table 41. By Country - South America Medical In Situ Hybridization Instrument Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Medical In Situ Hybridization Instrument Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Medical In Situ Hybridization Instrument Sales, (Units), 2024-2029
Table 46. Hölle & Hüttner AG (Intavis) Company Summary
Table 47. Hölle & Hüttner AG (Intavis) Medical In Situ Hybridization Instrument Product Offerings
Table 48. Hölle & Hüttner AG (Intavis) Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Hölle & Hüttner AG (Intavis) Key News & Latest Developments
Table 50. Xmatrx Company Summary
Table 51. Xmatrx Medical In Situ Hybridization Instrument Product Offerings
Table 52. Xmatrx Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Xmatrx Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Medical In Situ Hybridization Instrument Product Offerings
Table 56. Abbott Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Abbott Key News & Latest Developments
Table 58. Danaher Corporation (Leica Biosystems) Company Summary
Table 59. Danaher Corporation (Leica Biosystems) Medical In Situ Hybridization Instrument Product Offerings
Table 60. Danaher Corporation (Leica Biosystems) Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Danaher Corporation (Leica Biosystems) Key News & Latest Developments
Table 62. Allsheng Company Summary
Table 63. Allsheng Medical In Situ Hybridization Instrument Product Offerings
Table 64. Allsheng Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Allsheng Key News & Latest Developments
Table 66. Hangzhou Allsheng Instruments Company Summary
Table 67. Hangzhou Allsheng Instruments Medical In Situ Hybridization Instrument Product Offerings
Table 68. Hangzhou Allsheng Instruments Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hangzhou Allsheng Instruments Key News & Latest Developments
Table 70. Shenzhen Dartmon Biotechnology Company Summary
Table 71. Shenzhen Dartmon Biotechnology Medical In Situ Hybridization Instrument Product Offerings
Table 72. Shenzhen Dartmon Biotechnology Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Shenzhen Dartmon Biotechnology Key News & Latest Developments
Table 74. Zhejiang Orient Gene Biotech Company Summary
Table 75. Zhejiang Orient Gene Biotech Medical In Situ Hybridization Instrument Product Offerings
Table 76. Zhejiang Orient Gene Biotech Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Zhejiang Orient Gene Biotech Key News & Latest Developments
Table 78. Gene Tech Company Summary
Table 79. Gene Tech Medical In Situ Hybridization Instrument Product Offerings
Table 80. Gene Tech Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Gene Tech Key News & Latest Developments
Table 82. Shanghai Naai Experimental Instrument Company Summary
Table 83. Shanghai Naai Experimental Instrument Medical In Situ Hybridization Instrument Product Offerings
Table 84. Shanghai Naai Experimental Instrument Medical In Situ Hybridization Instrument Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Shanghai Naai Experimental Instrument Key News & Latest Developments
Table 86. Medical In Situ Hybridization Instrument Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Medical In Situ Hybridization Instrument Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Medical In Situ Hybridization Instrument Production by Region, 2018-2023 (Units)
Table 89. Global Medical In Situ Hybridization Instrument Production by Region, 2024-2029 (Units)
Table 90. Medical In Situ Hybridization Instrument Market Opportunities & Trends in Global Market
Table 91. Medical In Situ Hybridization Instrument Market Drivers in Global Market
Table 92. Medical In Situ Hybridization Instrument Market Restraints in Global Market
Table 93. Medical In Situ Hybridization Instrument Raw Materials
Table 94. Medical In Situ Hybridization Instrument Raw Materials Suppliers in Global Market
Table 95. Typical Medical In Situ Hybridization Instrument Downstream
Table 96. Medical In Situ Hybridization Instrument Downstream Clients in Global Market
Table 97. Medical In Situ Hybridization Instrument Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medical In Situ Hybridization Instrument Segment by Type in 2022
Figure 2. Medical In Situ Hybridization Instrument Segment by Application in 2022
Figure 3. Global Medical In Situ Hybridization Instrument Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Medical In Situ Hybridization Instrument Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Medical In Situ Hybridization Instrument Revenue, 2018-2029 (US$, Mn)
Figure 7. Medical In Situ Hybridization Instrument Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Medical In Situ Hybridization Instrument Revenue in 2022
Figure 9. By Type - Global Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 11. By Type - Global Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 12. By Type - Global Medical In Situ Hybridization Instrument Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 15. By Application - Global Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 16. By Application - Global Medical In Situ Hybridization Instrument Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 20. By Region - Global Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 21. By Country - North America Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 22. By Country - North America Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 23. US Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 28. Germany Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 29. France Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 37. China Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 41. India Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 43. By Country - South America Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 44. Brazil Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Medical In Situ Hybridization Instrument Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Medical In Situ Hybridization Instrument Sales Market Share, 2018-2029
Figure 48. Turkey Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Medical In Situ Hybridization Instrument Revenue, (US$, Mn), 2018-2029
Figure 52. Global Medical In Situ Hybridization Instrument Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Medical In Situ Hybridization Instrument by Region, 2022 VS 2029
Figure 54. Medical In Situ Hybridization Instrument Industry Value Chain
Figure 55. Marketing Channels

※参考情報

医療用インサイチュハイブリダイゼーション装置（Medical In Situ Hybridization Instrument）は、生物学的な研究や医療診断において、特定のDNAまたはRNAの配列を細胞や組織の中で可視化するための重要なツールです。この技術は、特に遺伝子発現の評価や微生物の検出、さらにはがんの診断において、多くの利点を提供します。

まず、インサイチュハイブリダイゼーション（ISH）は、特定の遺伝子に対するプローブを用いて、組織スライド内での遺伝物質の存在を確認する技術です。このプローブは、標的の配列に特異的に結合し、可視化されることで、対象の分子が存在する部位を特定できます。この過程は、細胞の生物学的な状況を理解する上で非常に貴重です。

医療用インサイチュハイブリダイゼーション装置は、通常、以下のような特徴を備えています。まず、高度な温度制御機能を持ち、プローブとのハイブリダイゼーション反応を最適化するための温度調整が可能です。また、リアルタイムで反応をモニタリングできる機能や、自動化されたプロセス管理により、効率的な作業が遂行できます。さらに、装置の多くは、ハイブリダイゼーションのプロトコルに合わせた多様なオプションやプログラムを搭載しており、ユーザーのニーズに応じた柔軟な操作が可能です。

種類としては、さまざまなバリエーションが存在しますが、大きく分けて二つのタイプが一般的です。一つは、光学顕微鏡と統合されたものです。これは、インサイチュハイブリダイゼーションの結果をモニタリングするために設計されており、プローブが結合した場合に色素反応を引き起こすことにより、特定の細胞や組織を視覚的に認識できます。もう一つは、フルオレセンス顕微鏡と併用する装置です。これにより、より高感度な検出や、複数のターゲット同時に可視化することが可能になります。

医療分野における用途は多岐にわたります。最も一般的な用途の一つは、がんの病理診断です。がん細胞では特定の遺伝子が変異していることが多く、これらの遺伝子の発現パターンを分析することで、腫瘍の性質を理解し、適切な治療法を選定する手助けができます。また、感染症の診断においても、特定の病原体やウイルスの存在を迅速に確認する手段として利用されます。例えば、ウイルス性肝炎や結核など、多くの感染症の診断に役立つ情報を提供します。

加えて、インサイチュハイブリダイゼーションは、遺伝子診断においても重要な役割を果たしています。遺伝性の疾患や異常に関する研究や、出生前診断に利用されることが増えており、正確な情報を基にした医療提供が可能になります。

関連技術としては、ポリメラーゼ連鎖反応（PCR）や次世代シーケンシング（NGS）が挙げられます。PCRは、特定のDNAを増幅する技術であり、ISHと組み合わせることで、より感度の高い結果を得ることができます。また、NGSは全ゲノムの解析を可能にし、ISHによる特定の遺伝子の活性と、全体の遺伝子構造との関連性を理解するための重要な手段となり得ます。

総じて、医療用インサイチュハイブリダイゼーション装置は、現代の生物学的研究や医療診断において欠かせない存在です。この技術は、病気の早期発見や予後の予測に重要な情報を提供するだけでなく、研究者たちが細胞内の分子の動態を正確に解明するための貴重な手段を提供します。今後の医療分野においても、その応用範囲はさらなる広がりを見せ、革新的な進展が期待される分野となるでしょう。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 目元用RFアンチエイジング機器のグローバル市場展望 2023年-2029年：携帯型、固定型
  • 網膜電図検査装置のグローバル市場展望 2023年-2029年：固定型、携帯型
  • 医療用超音波直腸プローブのグローバル市場展望 2023年-2029年：20cm、14cm、その他
  • 可溶性成長刺激発現遺伝子2タンパク質アッセイキットのグローバル市場展望 2023年-2029年：酵素免疫吸着測定キット、ウェスタンブロッティングキット
  • 熱傷サスペンデッドベッドのグローバル市場展望 2023年-2029年：サンドベッド、エアサスペンションベッド
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC13575 )"医療用インサイチュハイブリダイゼーション装置のグローバル市場展望 2023年-2029年：検体数12検体、検体数20検体、検体数40検体" (英文：Medical In Situ Hybridization Instrument Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。